20425 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two nitrogen atoms as the only ring heteroatoms, e.g. piperazine; Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
Ubiquitin ligase inhibitors and methods related thereto
#302Process for the production of an abuse-proofed dosage form
#303Serotonergic agents for treating sexual dysfunction
#304Serotonergic agents for treating sexual dysfunction
#305Non-sedating barbiturate compounds as neuroprotective agents
#306Abuse-proofed dosage form
#307Methods for treatment and management of lung cancer using 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione
#308Treatment of obstructive sleep apnea
#309Composition and method for improved bioavailability and enhanced brain delivery of 5,5-diphenyl barbituric acid
#310Methods and compositions using PDE4 modulators for treatment and management of central nervous system injury
#311Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
#312Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
#313Non-sedating barbituric acid derivatives
#314Method using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias
#315Protease inhibitors for treatment of wrinkles
#316Combination of proton pump inhibitor and sleep aid
#317Methods for treatment of multiple myeloma using cyclopropane carboxylic acid {2-[(is)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1 h-isoindol-4-yl}-amide
#318Pyrrolidineacetamide derivative alone or in combination for treatment of CNS disorders
#319Methods for treatment of cancers using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione
#320Use of dihydroimidazolones for the treatment of dogs
#321Compositions of a cyclooxygenase-2 selective inhibitor and an anticonvulsant agent for the treatment of central nervous system disorders
#322Pin1-modulating compounds and methods of use thereof
#323Abuse-proofed dosage form
#324Rectal gel with date palm phenolics and vanillic acid
#325Rectal gel with date palm phenolics and vanillic acid
#326Compound and method for treating diseases and disorders
#327Diethylammonium salts of phenyl-substituted thiobarbituric acid as anti-diabetic agents
#328Stable pentobarbital formulation